Navigation Links
The use of TaqMaster PCR Enhancer

Guy Adami, Department of Oral Medicine, University of Illinois in Chicago, USA
Vincent Prezioso, Eppendorf Scientific, Inc., Westbury, NY, USA

Introduction

Transgenic mice carry a fragment of foreign DNA that has been incorporated into their genome. The most common method of introducing recombinant DNA into the mouse genome is by microinjection of the DNA into the pronuclei of one-cell stage mouse embryos.

A fraction of these embryos develop into newborn mice which have the micro-injected DNA stably integrated in their genome. A second strategy for generating transgenic mice involves genetic manipulation of ES cells.

After electroporation with a carefully designed construct, the stem cells are screened for the integration of new DNA through homologous recombination.

ES cells that are positive for a homologous recombination event are then transplanted into blastocyst stage embryos in order to generate chimeric mice. In most cases, gene targeting is used to introduce mutations into specific genes in the mouse genome.

The transgenic DNA is typically transcribed and translated in a tissue-specific and stage-specific pattern that is determined by regulatory sequences present in the transgenic DNA. Consequently, transgenic mice represent an experimental system in which it is possible to study the consequences and/or pattern of expression (or lack thereof) of the new genetic information. Incorporated transgenes are often detected by genomic DNA isolation from a tissue sample, followed by PCR* amplification of a region of the inserted gene.

The tissue source most commonly used for genotyping is mouse tail (1), however, ear, toe, hair, and blood samples are also used. Typically, genomic DNA isolation procedures from tail slices involve long incubations (one hour to overnight) at high temperature in the presence of Proteinase K. One of the problems that researchers often see is inconsistency in the amplification of transgenic DNA caused by impurities in the template DNA: These often inhibit PCR reactions causing false negative or inconclusive results. Here, we describe a reliable method of achieving consistent amplification of genomic DNA with impurities using a
novel PCR enhancer.

The Eppendorf MasterTaq Kit contains the TaqMaster PCR enhancer that has been specially developed to improve the amplification of difficult templates by improving the thermostability of the Taq DNA Polymerase. TaqMaster also adsorbs impurities in the template making the Taq less sensitive to exogenous PCR
inhibiting contamination. Impure and GC-rich templates show increased yields and reproducible results.

Results

Six newborn mice were screened for the presence of a TGF alpha transgene. Mouse tail DNA (from last 2 mm of tail) was isolated by Proteinase K digestion
followed by heat inactivation as described (2).

Briefly, 2 mm of tail was placed directly into 200 l DNA Extraction Buffer with Nonionic Detergents (PBND) (3) in a 1.5 ml microcentrifuge tube. Next 2.5 l Proteinase K solution at 20 mg/ml (4) was added to each sample.

The samples were incubated at 55 C with occasional vortexing until tissue was degraded (~2 hours). Finally, the samples were boiled for 10 minutes (to inactivate the Proteinase K), and centrifuged for 5 minutes. 2 l of this reaction was used per PCR reaction. The primers used in the reaction are specific to the human TGF alpha cDNA and were synthesized as described (5).

The size of the expected amplified product is 182 bp. The PCR was split into two sets of reactions, with and without the TaqMaster, according to the manufacturer's specifications (6). After an initial incubation at 94 C for 5 minutes, 0.2 l was added to each reaction. The PCR was run for 29 cycles under the following conditions:
1. Denature 94 C, 1 minute
2. Hybridization 56 C, 30 seconds
3. Extension 70 C, 40 seconds

Figure 1 shows the results of the experiment. All results were confirmed by phenotypic analysis of adult transgenic animals (7).



Figure 1. The TaqMaster enhancer makes the PCR signal both stronger and much more consistent. This is a 1.5 % agarose gel run with TAE. Lanes: 1 & 14 = 1 kb ladder (Life Technologies), Lanes 2-7 PCR without enhancer (TaqMaster), Lanes 8 -13 with the TaqMaster and the markers again.

The lanes with reactions that do not contain the PCR enhancer show variability and artifacts such as primer-dimers (lanes 2-7). Note especially lanes 3 and 4 where a weak positive signal could lead to ambiguity about the results. In contrast, lanes 8 -13 show extremely consistent results. Positive animals can be clearly identified as those corresponding to lanes 9, 10 and 13.

Note that lanes 9 and 10, which are from the same template as lanes 3 and 4, show robust amplification with no primer-dimers or other artifacts. The other lanes with the TaqMaster also show no primer-dimers and strong signals in the case of positive animals.

This demonstrates that the TaqMaster has the effect of making these reactions more robust and consistent.

Conclusion

Eppendorf's TaqMaster PCR enhancer is ideal for PCR reactions that contain templates with impurities.

References
(1) Hogan, B. Manipulating the Mouse Embryo 1994, p. 296

(2) Perkin Elmer Cetus: Vol.#2 PEC1989, pp. 1-3

(3) PBND buffer contains:
50 mM KCl
10 mM Tris-HCl (ph 8.3)
2.5 mM MgCl
0.1 mg/ml gelatin
0.45 % v/v Nonidet P40 (NP40)
0.45% v/v Tween 20

(4) Proteinase K: Made fresh for each use! 20 mg Proteinase K is dissolved in 1 ml ddH O @ 4 C. Filter sterilize.

(5) Ji H.J., Zhang Q.Q., Leung B.S. Survey of oncogene and growth factor/receptor gene expression in cancer cells by intron-differential RNA/PCR. 1990 Jul 31; 170 (2): pp. 569-575

(6) PCR reaction mix for ten tubes consists of: Rxn. with enhancer:
25 l 10x Buffer
50 l TaqMaster PCR Enhancer
20 l dNTP at 2.5 M
2.5 l Primer 1 at 1 g/l
2.5 l Primer 2 at 1 g/l
130 l H O
+2 l Tail DNA
(out of 200 l total per 2 mm piece of tail)
Rxn. without enhancer:
25 l 10x Buffer
20 l dNTP at 2.5 M
2.5 l Primer 1 at 1 g/l 20 mer
2.5 l Primer 2 at 1 g/l 20 mer
180 l H O
+2 l Tail DNA
(out of 200 l total per 2 mm piece of tail)

(7) Jhappan C, Stahle C, Harkins RN, Fausto N, Smith GH, Merlino GT. TGF alpha overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. 1990 June 15; 61 (6): pp. 1137-1146


Applicational tip: PCR sample preparation





'"/>

Source:


Page: All 1 2 3 4 5

Related biology technology :

1. Signal Transduction Reporting Systems Using Cis-Acting Enhancer Elements
2. Optimizing pfuturbo DNA Polymerase Amplification Reactions with Perfect Match PCR Enhancer
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: The use TaqMaster PCR Enhancer

(Date:9/5/2008)... EAST LONGMEADOW, Mass., Sept. 5 /PRNewswire/...he symptoms associated with an enlarged prostate,n...ment to cure the,problem. biolitec, Inc. is please... Oregon is now offering its breakthrough LIFE(TM) ...or benign prostate hyperplasia (BPH),that quickly ...
(Date:9/5/2008)... Update on the Regulatory Strategy for ...r 5 /- TopoTarget,A/S (OMX:...A was received,on a Special Protocol Assessment (S...Peripheral T-Celle Lymphoma). This pivotal trial i...gin in Q4 2008. In June Fast Track,designation was...
(Date:9/5/2008)... LYNBROOK, N.Y., Sept. 5 /PRNewswire-FirstCal...n Board: BSTC), a biopharmaceutical company,develo...nounced today that,it has signed an agreement to s... future royalty obligations for Peyronie,s disease...h a one-time cash payment., BioSpecifics has modi...
(Date:9/4/2008)... BEDFORD, Mass., Sept. 4 /PRNewswire-FirstCal...ed that Glenn Muir, Chief Financial Officer,will ...are Unplugged,Conference being held September 9, 2...nterested parties are invited to listen to a live ...n Tuesday, September 9, 2008, at 1:35 PM.,Eastern...
Breaking Biology Technology:Revolutionary New In-Office EVOLVE(R) Laser Prostate Treatment Available Throughout Western Oregon 2Positive SPA Reply From the FDA for TopoTarget's Pivotal Trial With Belinostat in PTCL 2Positive SPA Reply From the FDA for TopoTarget's Pivotal Trial With Belinostat in PTCL 3Positive SPA Reply From the FDA for TopoTarget's Pivotal Trial With Belinostat in PTCL 4Positive SPA Reply From the FDA for TopoTarget's Pivotal Trial With Belinostat in PTCL 5BioSpecifics Technologies Corp. Buys Down Royalties for Peyronie's Disease 2Hologic to Present at the Morgan Stanley Global Healthcare Unplugged Conference 2
...low prices. When it comes to consumer goods, Ameri... product selection and fanatical commitment to low...going. We like our stuff cheap, and Wal-Mart is th...ans hate to love is getting loads of unfavorable a...ccessfully derailed its growth plans in certain pa...
...nn Stunden, chief information officer and director...at the University of Wisconsin-Madison, has announ... at the helm of campus technology. , ,"We have mad...," Stunden said. "Above all, I think we have stren...us and built a more collaborative model." , , St...
...thcare has data from a clinical case study confir...ed tomography (CT) scanner, is capable of capturin...s. The announcement was made at the annual meeting...,The clinical case study data, collected by Dr. Je...Radiology at Centre Cardiologique de Nord in Saint...
...iseases like Parkinson,s, Alzheimer,s, juvenile di... American families - including my own. Stem cell ...ay one day offer a cure to some of these diseases....llow partisan political ideology to get in the way...Wisconsin Legislature sent me a bill that would ha...
Other Biology Technology:Wal-Mart: How low can you go? 2Wal-Mart: How low can you go? 3Wal-Mart: How low can you go? 4Stunden to retire as UW-Madison CIO 2GE Healthcare's CT Scanner advances coronary imaging 2Standing up for stem cell research 2Standing up for stem cell research 3
(Date:9/4/2008)...WALNUT CREEK, Calif. Subtle genetic changes that c...ch as the dexterity characteristic of the human ha...eproduce in a model system, have nevertheless gene...s. In findings published online in the September 5...m the U.S. Department of Energy,s Lawrence Berkele...
(Date:9/4/2008)...ientists have discovered a gene enhancer, known as...n of the uniquely opposable human thumb, and possi...llow humans to walk on two legs, according to a pa...his study is the first to provide evidence of the ...are switches near genes in the human genome. , ...
(Date:9/4/2008)...tralian researchers and a pathology company have j...d system which may reveal a way to predict prematu...f Melbourne, the University of Newcastle and Symbi...esearch, engineering and pathology to develop a co...ature birth., About 17,000 pre-term births occur ...
(Date:9/4/2008)...at: , The CTRC-AACR San Antonio Breast Cancer Sy...in laboratory, translational and clinical breast c... and promising therapeutic approaches, as well as ...east cancer. , To help you take the best advanta...ated activities, we encourage you to visit www.sa...
Breaking Biology News(10 mins):Thumbs up -- a tiny ancestral remnant lends developmental edge to humans 2Thumbs up -- a tiny ancestral remnant lends developmental edge to humans 3Gene enhancer in evolution of human opposable thumb 2Gene enhancer in evolution of human opposable thumb 3World-first to predict premature births 2DOE publishes update of plan 3A Facilities for the Future of Science 3A A 20 Year Outlook 757 1DOE publishes update of plan 3A Facilities for the Future of Science 3A A 20 Year Outlook 757 2DOE publishes update of plan 3A Facilities for the Future of Science 3A A 20 Year Outlook 757 3DOE publishes update of plan 3A Facilities for the Future of Science 3A A 20 Year Outlook 757 4DOE publishes update of plan 3A Facilities for the Future of Science 3A A 20 Year Outlook 757 5Three Organizations Receive CEO Cancer Gold Standard 28TM 29 Accreditation 3462 1Three Organizations Receive CEO Cancer Gold Standard 28TM 29 Accreditation 3462 2Three Organizations Receive CEO Cancer Gold Standard 28TM 29 Accreditation 3462 3Coalition America Inc Again Named One of Georgias Fastest Growing Technology Companies in Deloittes Technology Fast 50 Program 3457 1Coalition America Inc Again Named One of Georgias Fastest Growing Technology Companies in Deloittes Technology Fast 50 Program 3457 2Prostate cancer increases hip fracture risk by eight times in 50 to 65 year olds 3455 1Prostate cancer increases hip fracture risk by eight times in 50 to 65 year olds 3455 2
...t shows that drug development for killer diseases ... Sickness has increased in recent years. This is d...the poor in developing countries and development o... demand. Researchers argue that the rate of develo...cs) would increase if more incentives were created...
...fferent ocean locations for the presence of an elu... gained new insight into the dwelling places of th...rvival. , The symbiosis between special algal spec...productive and biologically complex ecosystem, but...ished by new corals has been limited by the fact t...
...pace create in humans and animals so-called optica...ement in question. In a forward movement, the obje...se in size and objects further away hardly change ...the brain, there must be a computation of the visu...between their own movement and movement of their e...
... been shown to improve blood flow in diseased arte... heart attacks, a Monash University study publishe...evelopment for the Monash team that, in conjunctio... part of a revolution in the management of heart d...ntre for Vascular Health and his colleagues at Mon...
Other Biology News:Increase in drug development for killer diseases is not enough 2Ocean sampling yields environmental sources of coral symbionts 2Two nerve cells in direct contact 2Two nerve cells in direct contact 3Heart smart: new drug improves blood flow 2
Antibodies were affinity purified using epitopes specific to USP33 immobilized on solid support.
10% Normal Goat Serum from Invitrogen
This monoclonal antibody recognizes 30% of IgM-rheumatoid factor paraproteins from unrelated individuals. It does not cross-react with IgM, IgA, or IgG proteins lacking rheumatoid factor nor with p
Human IgG Fd. ELISA Specificity: (4) ,human IgG subclass 1 100% ,human IgG subclass 2 100% ,human IgG subclass 3 100% ,human IgG subclass 4 99% ,hu
Biology Products: